Pomalidomide Capsule
Product Images NDC 69097-037

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Pomalidomide (NDC 69097-037). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Api-structure (Api Structure)

Chemical structure of pomalidomide, showing its molecular framework including amine and carbonyl groups in its heterocyclic rings.*

FDA Label Image

Figure-1 (Figure 1)

A Kaplan-Meier survival curve comparing progression-free survival over months between two treatment groups: HD-DEX (solid blue line) and POM+LD-DEX (dashed red line). The graph shows the proportion of subjects remaining progression-free decreasing over time, with POM+LD-DEX group showing longer progression-free survival. Below the plot, a table displays the number of subjects at risk at various time points for each group.*

FDA Label Image

Figure-2 (Figure 2)

A Kaplan-Meier survival plot comparing overall survival (months) between two groups: HD-DEX and POM+LD-DEX. The y-axis shows the proportion of subjects surviving, and the x-axis shows time in months. Below the graph, numbers of subjects at risk over time are presented for each group.*

FDA Label Image

1-mg-100-bottle-pack (Poma1mg100bottlepack)

Label for Pomalidomide capsules 1 mg by Cipla USA Inc. The label includes the dosage strength of 1 mg per capsule, a warning about potential human birth defects, storage instructions, and manufacturer information. It also notes the package contains 100 capsules and highlights that batch overprinting for serial number, expiry, and lot number will be added during commercial packing.*

FDA Label Image

1mg-21-bottle-pack (Poma1mg21bottlepack)

Pomalidomide 1 mg oral capsules label from Cipla USA Inc. The label includes dosage form, strength, prescription status (Rx only), NDC code 69097-036-81, and a warning about potential for human birth defects. It directs dispensing of a Medication Guide and includes storage instructions. Manufacturing and packaging information is provided along with a barcode and a section for batch overprinting of serial number, expiry, and lot details.*

FDA Label Image

2mg-100-bottle-pack (Poma2mg100bottlepack)

Pomalidomide 2 mg oral capsules label from Cipla USA Inc. The label includes product name, strength, dosage form, NDC number 69097-037-07, a warning for potential human birth defects, storage conditions, manufacturer details, and placeholders for batch information such as serial number, expiration date, and lot number.*

FDA Label Image

2mg-21-bottle-pack (Poma2mg21bottlepack)

Label for Pomalidomide Capsules 2 mg oral capsules by Cipla USA Inc. The label includes a warning about potential human birth defects, storage instructions, manufacturer information, and space for batch details such as serial number, expiry, and lot number. The package contains 21 capsules.*

FDA Label Image

3mg-100-bottle-pack (Poma3mg100bottlepack)

Pomalidomide 3 mg oral capsules label from Cipla USA Inc. The label includes the product name, dosage strength (3 mg), prescription drug status, and a warning about potential human birth defects. Instructions for storage temperature and child safety, as well as manufacturer information from Cipla Ltd., Goa, India, and Cipla USA, Inc., are also shown. There is a designated area for batch overprinting including serial number, expiration, and lot number.*

FDA Label Image

3mg-21-bottle-pack (Poma3mg21bottlepack)

Pomalidomide 3 mg oral capsules packaging label from Cipla USA Inc. The label includes the drug name, strength, dosage form, and a warning about potential human birth defects. It notes storage instructions, manufacturing details from Cipla Ltd, India, and Cipla USA Inc., and indicates the package contains 21 capsules with area reserved for batch overprinting of serial number, expiry, and lot information.*

FDA Label Image

4mg-100-bottle-pack (Poma4mg100bottlepack)

Pomalidomide Capsules 4 mg oral capsules label from Cipla USA Inc. The label includes prescription-only status, a warning about potential human birth defects, instructions to dispense the accompanying Medication Guide, and storage information. The package size indicated is 100 capsules, with manufacturing details and batch overprinting area noted for serial number, expiry, and lot during commercial packing.*

FDA Label Image

4mg-21-bottle-pack (Poma4mg21bottlepack)

Pomalidomide 4 mg capsules label from Cipla USA Inc. The label states the dosage strength as 4 mg per capsule and indicates it is a prescription drug. It includes a warning about potential birth defects and advises dispensing the accompanying Medication Guide. Storage instructions and manufacturing details by Cipla Ltd. and Cipla USA, Inc. are provided, along with a barcode and areas designated for batch overprinting.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.